State Of Wisconsin Investment Board Prelude Therapeutics Inc Transaction History

State Of Wisconsin Investment Board

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$3.32 - $5.63 $2,988 - $5,067	-900 Reduced 4.59%	18,700 $71,000
Q1 2024 May 14, 2024	SELL	$2.68 - $4.84 $13,936 - $25,168	-5,200 Reduced 20.97%	19,600 $92,000
Q4 2023 Feb 12, 2024	SELL	$1.69 - $4.37 $62,192 - $160,816	-36,800 Reduced 59.74%	24,800 $105,000
Q3 2023 Nov 14, 2023	SELL	$2.74 - $4.79 $45,758 - $79,993	-16,700 Reduced 21.33%	61,600 $190,000
Q2 2023 Aug 14, 2023	SELL	$4.45 - $8.12 $52,955 - $96,627	-11,900 Reduced 13.19%	78,300 $352,000
Q1 2023 May 15, 2023	SELL	$4.58 - $7.34 $46,716 - $74,868	-10,200 Reduced 10.16%	90,200 $514,000
Q4 2022 Feb 14, 2023	SELL	$4.61 - $8.5 $40,107 - $73,950	-8,700 Reduced 7.97%	100,400 $606,000
Q3 2022 Nov 14, 2022	SELL	$5.0 - $8.82 $90,500 - $159,642	-18,100 Reduced 14.23%	109,100 $721,000
Q2 2022 Aug 15, 2022	BUY	$4.0 - $7.55 $210,800 - $397,885	52,700 Added 70.74%	127,200 $664,000
Q1 2022 May 13, 2022	BUY	$6.9 - $13.22 $422,280 - $809,064	61,200 Added 460.15%	74,500 $514,000
Q1 2021 May 17, 2021	BUY	$39.27 - $91.68 $522,291 - $1.22 Million	13,300 New	13,300 $576,000

35.7M

500

300

Ticker PRLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,369,200
Market Cap $34.6M
Description
Prelude Therapeutics Incorporated, a clinical-stage precision oncology company, focuses on the discovery and development of novel precision cancer medicines to underserved patients. It is developing PRT543 that is in Phase 1 clinical trials in select solid tumors and myeloid malignancies; and PRT811, which is in Phase 1 clinical trials in solid ...

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

Stay updated on State Of Wisconsin Investment Board with notifications on news.